z-logo
open-access-imgOpen Access
Pembrolizumab in endometrial cancer: Where we stand now (Review)
Author(s) -
Aikaterini AravantinouFatorou,
Αngeliki Andrikopoulou,
Michalis Liontos,
Oraianthi Fiste,
Vasiliki Georgakopoulou,
Meletios Α. Dimopoulos,
Maria Gavriatopoulou,
Flora Zagouri
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.13082
Subject(s) - pembrolizumab , medicine , endometrial cancer , oncology , cancer , clinical trial , medline , immunotherapy , political science , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom